88 related articles for article (PubMed ID: 230927)
1. Effects of clofibrate on plasma lipids and high-density lipoprotein levels in renal allograft recipients.
Bagdade JD; Shantharam VV; Sollek M; Albers JJ
Clin Nephrol; 1979 Aug; 12(2):83-6. PubMed ID: 230927
[TBL] [Abstract][Full Text] [Related]
2. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
3. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
[TBL] [Abstract][Full Text] [Related]
4. Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis.
Goldberg AP; Applebaum-Bowden DM; Bierman EL; Hazzard WR; Haas LB; Sherrard DJ; Brunzell JD; Huttunen JK; Ehnholm C; Nikkila EA
N Engl J Med; 1979 Nov; 301(20):1073-6. PubMed ID: 226883
[TBL] [Abstract][Full Text] [Related]
5. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
Nye ER; Sutherland WH; Temple Wa
N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550
[TBL] [Abstract][Full Text] [Related]
6. Plasma high-density lipoprotein concentrations in chronic-hemodialysis and renal-transplant patients.
Bagdade JD; Albers JJ
N Engl J Med; 1977 Jun; 296(25):1436-9. PubMed ID: 194152
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities in the composition of serum high density lipoprotein in renal transplant recipients.
Jung K; Neumann R; Scholz D; Nugel E
Clin Nephrol; 1982 Apr; 17(4):191-4. PubMed ID: 7042146
[TBL] [Abstract][Full Text] [Related]
8. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.
Kimak E; Ksiazek A; Baranowicz-Gaszczyk I; Solski J
Ren Fail; 2007; 29(6):705-12. PubMed ID: 17763166
[TBL] [Abstract][Full Text] [Related]
9. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.
Wilson DE; Lees RS
J Clin Invest; 1972 May; 51(5):1051-7. PubMed ID: 4341500
[TBL] [Abstract][Full Text] [Related]
10. Changes of plasma lipids and lipoprotein levels during danazol treatment for endometriosis.
Schweppe KW; Assmann G
Horm Metab Res; 1984 Nov; 16(11):593-7. PubMed ID: 6510890
[TBL] [Abstract][Full Text] [Related]
11. Lipid relation ships in dialysis and renal transplant patients.
Nicholls AJ; Cumming AM; Catto GR; Edward N; Engeset J
Q J Med; 1981; 50(198):149-60. PubMed ID: 7029600
[TBL] [Abstract][Full Text] [Related]
12. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
Stanely Mainzen Prince P; Kannan NK
J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
[TBL] [Abstract][Full Text] [Related]
14. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
[TBL] [Abstract][Full Text] [Related]
15. Diurnal lipid and lipoprotein profiles with bezafibrate and clofibrate in healthy volunteers.
Oster P; Schlierf G; Lang PD; Mordasini R; Vollmar J
Pharmatherapeutica; 1985; 4(5):267-77. PubMed ID: 4070320
[TBL] [Abstract][Full Text] [Related]
16. Carbohydrate restriction and dietary cholesterol distinctly affect plasma lipids and lipoprotein subfractions in adult guinea pigs.
Torres-Gonzalez M; Leite JO; Volek JS; Contois JH; Fernandez ML
J Nutr Biochem; 2008 Dec; 19(12):856-63. PubMed ID: 18495466
[TBL] [Abstract][Full Text] [Related]
17. Relation of cyclosporine blood levels to adverse effects on lipoproteins.
Kuster GM; Drexel H; Bleisch JA; Rentsch K; Pei P; Binswanger U; Amann FW
Transplantation; 1994 May; 57(10):1479-83. PubMed ID: 8197611
[TBL] [Abstract][Full Text] [Related]
18. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients.
Chen ST; Ferng SH; Yang CS; Peng SJ; Lee HR; Chen JR
Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
[TBL] [Abstract][Full Text] [Related]
20. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension.
Lacourcière Y; Gagné C
J Hum Hypertens; 1993 Apr; 7(2):149-52. PubMed ID: 8510087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
